(6-broMopyridin-2-yl)(1-Methylpiperidin-4-yl)Methanone CAS:613678-08-3
The structural characteristics of bromopyridine methylpiperidone are significant: Pyridine Ring: The presence of a bromine-substituted pyridine ring provides aromatic stability and influences its electronic properties, crucial for molecular interactions. Methylpiperidone Moiety: Central to its structure is the methylpiperidone group, which enhances solubility and influences its pharmacokinetic profile. Ketone Functionality: The ketone group at the terminus of the structure offers potential for chemical derivatization and interaction with biological targets. Chemical Applications Bromopyridine methylpiperidone demonstrates broad utility across various chemical contexts: Medicinal Chemistry: It serves as a scaffold for designing analogs with potential pharmaceutical applications, targeting neurological disorders and other therapeutic areas. Drug Development: Used in the synthesis of novel therapeutics due to its structural adaptability and ability to modulate biological activities. Biological Assays: Employed in biochemical assays to study receptor binding and enzymatic inhibition, facilitating drug discovery efforts. Pharmacological Potential Research into its pharmacological properties suggests several potential applications: Neurological Disorders: The methylpiperidone structure and bromopyridine ring contribute to its potential as a central nervous system (CNS) agent, including for treatments related to pain management or neurodegenerative diseases. Antimicrobial Activity: The presence of bromine and ketone functionalities may confer antimicrobial properties, making it a candidate for research against infectious diseases. Metabolic Stability: Structural features influence metabolic pathways and bioavailability, crucial for optimizing drug efficacy and safety profiles. Future Directions Future research directions for bromopyridine methylpiperidone include: Structure-Activity Relationships: Further exploring modifications to its structure to enhance specific pharmacological activities and minimize off-target effects. Formulation Development: Investigating formulation strategies to improve solubility and bioavailability, enhancing its clinical utility. Toxicological Studies: Comprehensive assessment of its safety profile and potential side effects to ensure suitability for clinical applications and environmental impact. Conclusion In conclusion, bromopyridine methylpiperidone stands as a versatile compound in medicinal chemistry, owing to its unique structural attributes and pharmacological diversity. Its potential in drug discovery and development underscores opportunities for creating targeted therapeutics across various therapeutic areas. Continued research into its synthesis methodologies, pharmacological effects, and broader applications promises to uncover further capabilities, solidifying its significance in modern pharmaceutical research and therapeutic innovation.
Composition | C12H15BrN2O |
Assay | 99% |
Appearance | white powder |
CAS No. | 613678-08-3 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |